Published in J Exp Med on December 01, 1968
IgA subclasses in various secretions and in serum. Immunology (1982) 2.43
Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest (1980) 2.11
Proteolytic degradation of exocrine and serum immunoglobulins. J Clin Invest (1970) 1.97
Differential susceptibility of human IgA immunoglobulins to streptococcal IgA protease. J Clin Invest (1974) 1.91
Immunochemical studies in four cases of alpha chain disease. J Clin Invest (1969) 1.90
Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest (1983) 1.86
Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol (1985) 1.80
Immunocytoma o' mice an' men. Br Med J (1971) 1.74
Ecology and nature of immunoglobulin A1 protease-producing streptococci in the human oral cavity and pharynx. Infect Immun (1981) 1.62
Distribution of IgA 1 and IgA 2 plasma cells in various normal human tissues and in the jejunum of plasma IgA-deficient patients. Clin Exp Immunol (1978) 1.61
Loss of antibody activity in human immunoglobulin A exposed extracellular immunoglobulin A proteases of Neisseria gonorrhoeae and Streptococcus sanguis. Infect Immun (1977) 1.60
The demonstration and function of antibodies in the gastrointestinal tract. Gut (1972) 1.53
Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J Clin Invest (1984) 1.44
Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens. J Exp Med (1980) 1.44
Immunoconglutinins in human saliva--a group of unusual IgA antibodies. Immunology (1970) 1.35
An immunological study during post-transplantation follow-up of a case of severe combined immunodeficiency. Clin Exp Immunol (1972) 1.29
IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci U S A (1982) 1.29
Absence of disulfide bonds linking the heavy and light chains: a property of a genetic variant of gamma-A2 globulins. Proc Natl Acad Sci U S A (1970) 1.27
Metabolic properties of human IgA subclasses. Clin Exp Immunol (1973) 1.26
Detection of immunoglobulin A1 protease-induced Fab alpha fragments on dental plaque bacteria. Infect Immun (1991) 1.14
Am(1), the first genetic marker of human immunoglobulin A. Proc Natl Acad Sci U S A (1969) 1.12
Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immun (1994) 1.02
IgA subclasses of human colostral antibodies specific for microbial and food antigens. Clin Exp Immunol (1989) 1.01
The nonplanar secretory IgA2 and near planar secretory IgA1 solution structures rationalize their different mucosal immune responses. J Biol Chem (2008) 0.99
Quantification and distribution of chicken immunoglobulins IgA, IgM and IgG in serum and secretions. Immunology (1974) 0.96
In vitro regulation of IgA subclass synthesis. I. Discordance between plasma cell production and antibody secretion. J Exp Med (1982) 0.96
Porcine IgG: structure, genetics, and evolution. Immunogenetics (2008) 0.96
Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. Infect Immun (2000) 0.96
Heavy-chain variable regions in normal and pathological immunolobulins. Proc Natl Acad Sci U S A (1971) 0.93
Human secretory immunoglobulins. VI. Association of free secretory piece with serum IgA in vitro. Immunology (1971) 0.93
Characterization of the IgA immunocyte population and its product in a patient with excessive intestinal formation of IgA. Clin Exp Immunol (1977) 0.90
Molecular size heterogeneity of immunoglobulins in health and disease. Clin Exp Immunol (1990) 0.84
Atypical IgA with hidden light chain. Clin Exp Immunol (1970) 0.84
Structural characterization of a human monoclonal IgA protein. Clin Exp Immunol (1971) 0.83
Henry G. Kunkel 1916-1983. An appreciation of the man and his scientific contributions & a bibliography of his research papers. J Exp Med (1985) 0.82
Studies on the products of peptic digestion of IgA. Immunology (1971) 0.81
Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines. Clin Exp Immunol (1998) 0.80
Distribution of IgA1 and IgA2 subclasses in normal bone marrow trephines and in trephines infiltrated by IgA producing multiple myeloma. J Clin Pathol (1987) 0.78
Colonic bacterial proteases to IgA1 and sIgA in patients with ulcerative colitis. Gut (1987) 0.75
Protein contents and binding modes of immunoglobulin-amylase complexes. J Clin Pathol (1982) 0.75
A new genetic polymorphism of human serum: 2 macroglobulin (AL-M). Am J Hum Genet (1972) 0.75
Reduction of gamma-globulins. Arch Biochem Biophys (1962) 13.22
Zone electrophoresis. Methods Biochem Anal (1954) 10.49
Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med (1968) 5.72
The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva. J Exp Med (1966) 3.97
THE SELECTIVE OCCURENCE OF GAMMA-1A GLOBULINS IN CERTAIN BODY FLUIDS. J Clin Invest (1963) 3.20
The evolutionary origins of the immunoglobulins. Proc Natl Acad Sci U S A (1966) 2.95
Variations in the S-S bridges of immunoglobins G: interchain disulfide bridges of gamma G3 myeloma proteins. J Mol Biol (1968) 2.57
Variations in amino-acid sequence near the disulphide bridges of Bence-Jones proteins. Nature (1966) 2.14
Subclasses of human immunoglobulin a based on differences in the alpha polypeptide chains. Science (1966) 1.79
Studies on the structure of mouse gamma-A myeloma proteins. Biochemistry (1968) 1.78
Subgroups of gamma-A immune globulins. Proc Soc Exp Biol Med (1966) 1.73
Polypeptide chain structure of rabbit immunoglobulins. 3. Secretory gamma-A-immunoglobulin from colostrum. Biochemistry (1967) 1.70
Phylogenetic origins of antibody structure. 3. Antibodies in the primary immune response of the sea lamprey, Petromyzon marinus. J Exp Med (1968) 1.70
The use of urea-starch-gel electrophoresis in studies of reductive cleavage of an alpha 2-macroglobulin. Biochim Biophys Acta (1960) 1.66
Comparative immunological studies of the immune globulins of human milk and of blood serum. Int Arch Allergy Appl Immunol (1961) 1.65
A model for colostral IgA. Proc Natl Acad Sci U S A (1966) 1.53
Distribution of alpha-chain subclasses in normal and pathological IgA-globulins. Immunology (1968) 1.23
The specific cleavage of immunoglobulin polypeptide chains at cysteinyl residues. J Biol Chem (1968) 1.07
Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med (1967) 10.22
Interaction of aggregated -globulin with B lymphocytes. J Exp Med (1972) 9.29
Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest (1966) 8.64
Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med (1971) 8.22
Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol (1966) 7.40
Individual Antigenic Specificity of Isolated Antibodies. Science (1963) 7.27
Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion. Immunology (1970) 6.89
Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med (1968) 5.72
Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin. J Exp Med (1971) 5.43
The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science (1987) 5.32
Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. J Clin Invest (1973) 5.31
QUANTITATIVE ANTISTREPTOKINASE STUDIES IN PATIENTS INFECTED WITH GROUP A HEMOLYTIC STREPTOCOCCI: A COMPARISON WITH SERUM ANTISTREPTOLYSIN AND GAMMA GLOBULIN LEVELS WITH SPECIAL REFERENCE TO THE OCCURRENCE OF RHEUMATIC FEVER. J Clin Invest (1948) 5.25
Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels. Clin Exp Immunol (1970) 5.10
Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia. J Clin Invest (1971) 4.98
Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes. J Exp Med (1975) 4.96
Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity. J Exp Med (1973) 4.93
IgG on lymphocyte surfaces; technical problems and the significance of a third cell population. J Immunol (1975) 4.92
Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell (1986) 4.71
Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease. J Exp Med (1971) 4.62
Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med (1973) 4.46
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol (1994) 4.37
Antigenic specificities related to the cold agglutinin activity of gamma M globulins. Science (1968) 4.32
The minimal number of class II MHC-antigen complexes needed for T cell activation. Science (1990) 4.09
Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol (1998) 3.95
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell (1993) 3.80
Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med (1979) 3.76
Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J Immunol (1984) 3.72
Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69
Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature (1987) 3.63
Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction. Clin Immunol Immunopathol (1973) 3.55
Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science (1992) 3.39
Studies on the capacity of B cells to serve as antigen-presenting cells. J Immunol (1981) 3.38
Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement. J Exp Med (1974) 3.38
Human immunoglobulins: classes, subclasses, genetic variants, and idiotypes. Adv Immunol (1973) 3.25
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell (1992) 3.24
Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies. J Clin Invest (1974) 3.24
Receptors for aggregated IgG on mouse lymphocytes: their presence on thymocytes, thymus-derived, and bone marrow-derived lymphocytes. J Exp Med (1974) 3.21
Identification of human B and T lymphocytes by scanning electron microscopy. J Exp Med (1973) 3.21
Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity. J Exp Med (1978) 3.18
Structure and function of immunoglobulin A. Prog Allergy (1972) 3.14
Antigen presentation by normal B cells, B cell tumors, and macrophages: functional and biochemical comparison. J Immunol (1982) 3.08
Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line. J Exp Med (1977) 2.98
The reaction of monomeric and aggregated immunoglobulins with C1. Immunochemistry (1971) 2.96
Occurrence of surface IgM, IgD, and free light chains of human lymphocytes. J Exp Med (1974) 2.93
Hidden rheumatoid factors with specificity for native gamma globulins. Arthritis Rheum (1966) 2.87
Lymphocytes in human immunodeficiency states: a study of membrane-associated immunoglobulins. Eur J Immunol (1971) 2.86
Studies of the Vi (gamma-2c) subgroup of gamma-globulin. A relationship between concentration and genetic type among normal individuals. J Exp Med (1967) 2.82
Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. J Exp Med (1980) 2.76
Occurrence of -globulin complexes in serum and joint fluid of rheumatoid arthritis patients: use of monoclonal rheumatoid factors as reagents for their demonstration. J Exp Med (1971) 2.75
Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci U S A (1989) 2.73
Mannan antigenemia in the diagnosis of invasive Candida infections. J Clin Invest (1976) 2.69
The small subunit of HL-A antigens is beta 2-microglobulin. J Exp Med (1973) 2.68
Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells. J Exp Med (1977) 2.66
Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum (1975) 2.65
Systemic lupus erythematosus: prototype of immune complex nephritis in man. J Exp Med (1971) 2.64
The human Ia system. Adv Immunol (1979) 2.62
Similarities in the light chains of anti-gamma-globulins showing cross-idiotypic specificities. J Exp Med (1974) 2.60
Immunological self, nonself discrimination. Science (1987) 2.59
Idiotypic determinants of immunoglobulin M detected on the surface of human lymphocytes by cytotoxicity assays. J Exp Med (1972) 2.47
Antibodies to polynucleotides: distribution in human serums. Science (1969) 2.43
Interaction between a "processed" ovalbumin peptide and Ia molecules. Proc Natl Acad Sci U S A (1986) 2.42
The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J Clin Invest (1973) 2.42
Human dendritic cells: major stimulators of the autologous and allogeneic mixed leucocyte reactions. Clin Exp Immunol (1982) 2.41
Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med (1978) 2.39
Protein A reactivity with mouse immunoglobulins. Structural relationship between some mouse and human immunoglobulins. J Immunol (1970) 2.38
Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells. J Exp Med (1973) 2.37
Thymus-derived (T) cell immunoglobulins. Presence of a receptor site for IgG and absence of large amounts of "buried" Ig determinants on T cells. J Exp Med (1972) 2.35
Immunoglobulins on the surface of lymphocytes. 3. Bursal origin of surface immunoglobulins on chicken lymphocytes. J Immunol (1971) 2.33
Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis. Arthritis Rheum (1981) 2.30
Similar idiotypic specificity for the membrane IgD and IgM of human B lymphocytes. J Immunol (1975) 2.28
Human T cell hybridomas secreting factors for IgA-specific help, polyclonal B cell activation, and B cell proliferation. J Exp Med (1982) 2.27
A new mouse immunoglobulin: IgG3. J Exp Med (1971) 2.27
The joint-fluid gammaG-globulin complexes and their relationship to intraarticular complement dimunition. Ann N Y Acad Sci (1969) 2.26
Requirements for the processing of antigens by antigen-presenting B cells. I. Functional comparison of B cell tumors and macrophages. J Immunol (1982) 2.25
The interaction between protein-derived immunogenic peptides and Ia. Immunol Rev (1987) 2.24
Idiotype-like molecules on cells of a human T cell leukemia. J Exp Med (1983) 2.19
Aggregation of gamma-G3 proteins: relevance to the hyperviscosity syndrome. J Clin Invest (1970) 2.19
Cryoimmunoglobulins. Semin Hematol (1973) 2.18
The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias. J Exp Med (1975) 2.13
Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc Natl Acad Sci U S A (1974) 2.13
Immunologic studies concerning the pulmonary lesions in Goodpasture's syndrome. Am J Pathol (1969) 2.11
Definition of specific peptide motifs for four major HLA-A alleles. J Immunol (1994) 2.11
Lymphocyte binding of aggregated IgG and surface Ig staining in chronic lymphocytic leukaemia. Clin Exp Immunol (1973) 2.11
Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions. J Exp Med (1973) 2.11
Variable patterns of immunoglobulin and complement deposition in the kidneys of patients with systemic lupus erythematosus. Am J Pathol (1969) 2.11
Experimental approaches tohomogenous antibody populations. iIndividual antigenic specificity, cross specificity and diversity of human antibodies. Fed Proc (1970) 2.10
An immunofluorescent study of the skin lesions in systemic lupus erythematosus. Arthritis Rheum (1966) 2.07
Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol (1994) 2.07
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J Immunol (1995) 2.05
Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus. J Immunol (1972) 2.02
Stimulation of human B lymphocytes by antibodies to IgM and IgG: functional evidence for the expression of IgG on B-lymphocyte surface membranes. Clin Immunol Immunopathol (1980) 2.00
Induction of polyclonal antibody synthesis by human allogeneic and autologous helper factors. J Exp Med (1979) 1.98
The nature of the stimulatory cell in human allogeneic and autologous MLC reactions; role of isolated IgM-bearing B cells. J Immunol (1979) 1.96
B cells as antigen-presenting cells: the requirement for B cell activation. J Immunol (1983) 1.93
Autologous peptides constitutively occupy the antigen binding site on Ia. Science (1988) 1.92
Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses. J Immunol (1985) 1.91
Specific concentration of polynucleotide immune complexes in the cryoprecipitates of patients with systemic lupus erythematosus. J Clin Invest (1975) 1.91